nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—Mycophenolate mofetil—psoriasis	0.12	0.168	CbGbCtD
Fidaxomicin—ABCB1—Betamethasone—psoriasis	0.103	0.144	CbGbCtD
Fidaxomicin—ABCB1—Prednisolone—psoriasis	0.102	0.142	CbGbCtD
Fidaxomicin—ABCB1—Hydrocortisone—psoriasis	0.0964	0.135	CbGbCtD
Fidaxomicin—ABCB1—Prednisone—psoriasis	0.096	0.134	CbGbCtD
Fidaxomicin—ABCB1—Cyclosporine—psoriasis	0.091	0.127	CbGbCtD
Fidaxomicin—ABCB1—Dexamethasone—psoriasis	0.0599	0.0837	CbGbCtD
Fidaxomicin—ABCB1—Methotrexate—psoriasis	0.0482	0.0673	CbGbCtD
Fidaxomicin—Abdominal distension—Mycophenolate mofetil—psoriasis	0.00118	0.00416	CcSEcCtD
Fidaxomicin—Dysphagia—Mycophenolate mofetil—psoriasis	0.00117	0.00414	CcSEcCtD
Fidaxomicin—Pruritus—Methoxsalen—psoriasis	0.00115	0.00404	CcSEcCtD
Fidaxomicin—Anaemia—Hydroxyurea—psoriasis	0.00114	0.00403	CcSEcCtD
Fidaxomicin—Abdominal pain—Calcitriol—psoriasis	0.00114	0.00403	CcSEcCtD
Fidaxomicin—Dyspepsia—Acitretin—psoriasis	0.00113	0.00399	CcSEcCtD
Fidaxomicin—Decreased appetite—Acitretin—psoriasis	0.00112	0.00394	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Acitretin—psoriasis	0.00111	0.00391	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.00111	0.0039	CcSEcCtD
Fidaxomicin—Abdominal distension—Prednisolone—psoriasis	0.0011	0.00388	CcSEcCtD
Fidaxomicin—Constipation—Acitretin—psoriasis	0.0011	0.00388	CcSEcCtD
Fidaxomicin—Neutropenia—Mycophenolate mofetil—psoriasis	0.0011	0.00387	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Hydrocortisone—psoriasis	0.00109	0.00384	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Cyclosporine—psoriasis	0.00109	0.00382	CcSEcCtD
Fidaxomicin—Abdominal distension—Hydrocortisone—psoriasis	0.00108	0.00379	CcSEcCtD
Fidaxomicin—Dizziness—Methoxsalen—psoriasis	0.00107	0.00378	CcSEcCtD
Fidaxomicin—Hypersensitivity—Calcitriol—psoriasis	0.00107	0.00375	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Mycophenolate mofetil—psoriasis	0.00106	0.00373	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Acitretin—psoriasis	0.00105	0.00371	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.00105	0.00369	CcSEcCtD
Fidaxomicin—Malnutrition—Mycophenolic acid—psoriasis	0.00104	0.00365	CcSEcCtD
Fidaxomicin—Pruritus—Calcitriol—psoriasis	0.00102	0.0036	CcSEcCtD
Fidaxomicin—Rash—Methoxsalen—psoriasis	0.00102	0.0036	CcSEcCtD
Fidaxomicin—Dermatitis—Methoxsalen—psoriasis	0.00102	0.0036	CcSEcCtD
Fidaxomicin—Flatulence—Mycophenolic acid—psoriasis	0.00102	0.0036	CcSEcCtD
Fidaxomicin—Abdominal pain—Acitretin—psoriasis	0.00102	0.00358	CcSEcCtD
Fidaxomicin—Headache—Methoxsalen—psoriasis	0.00102	0.00358	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Cyclosporine—psoriasis	0.00101	0.00357	CcSEcCtD
Fidaxomicin—Abdominal distension—Triamcinolone—psoriasis	0.00101	0.00357	CcSEcCtD
Fidaxomicin—Nervous system disorder—Hydroxyurea—psoriasis	0.00099	0.00349	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Mycophenolate mofetil—psoriasis	0.00099	0.00349	CcSEcCtD
Fidaxomicin—Skin disorder—Hydroxyurea—psoriasis	0.000981	0.00346	CcSEcCtD
Fidaxomicin—Nausea—Methoxsalen—psoriasis	0.000964	0.00339	CcSEcCtD
Fidaxomicin—Anaemia—Mycophenolic acid—psoriasis	0.000958	0.00337	CcSEcCtD
Fidaxomicin—Hypersensitivity—Acitretin—psoriasis	0.000948	0.00334	CcSEcCtD
Fidaxomicin—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000945	0.00333	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Prednisone—psoriasis	0.000921	0.00324	CcSEcCtD
Fidaxomicin—Vomiting—Calcitriol—psoriasis	0.000919	0.00324	CcSEcCtD
Fidaxomicin—Rash—Calcitriol—psoriasis	0.000912	0.00321	CcSEcCtD
Fidaxomicin—Dermatitis—Calcitriol—psoriasis	0.000911	0.00321	CcSEcCtD
Fidaxomicin—Pruritus—Acitretin—psoriasis	0.00091	0.00321	CcSEcCtD
Fidaxomicin—Pruritus—Fluocinolone Acetonide—psoriasis	0.000908	0.0032	CcSEcCtD
Fidaxomicin—Headache—Calcitriol—psoriasis	0.000906	0.00319	CcSEcCtD
Fidaxomicin—Dyspnoea—Hydroxyurea—psoriasis	0.0009	0.00317	CcSEcCtD
Fidaxomicin—Dyspepsia—Hydroxyurea—psoriasis	0.000889	0.00313	CcSEcCtD
Fidaxomicin—Decreased appetite—Hydroxyurea—psoriasis	0.000878	0.00309	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000876	0.00309	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000872	0.00307	CcSEcCtD
Fidaxomicin—Constipation—Hydroxyurea—psoriasis	0.000864	0.00304	CcSEcCtD
Fidaxomicin—Dry mouth—Mycophenolic acid—psoriasis	0.000863	0.00304	CcSEcCtD
Fidaxomicin—Nausea—Calcitriol—psoriasis	0.000859	0.00303	CcSEcCtD
Fidaxomicin—Dizziness—Acitretin—psoriasis	0.000851	0.003	CcSEcCtD
Fidaxomicin—Dizziness—Fluocinolone Acetonide—psoriasis	0.000848	0.00299	CcSEcCtD
Fidaxomicin—Malnutrition—Cyclosporine—psoriasis	0.000838	0.00295	CcSEcCtD
Fidaxomicin—Nervous system disorder—Mycophenolic acid—psoriasis	0.00083	0.00292	CcSEcCtD
Fidaxomicin—Flatulence—Cyclosporine—psoriasis	0.000826	0.00291	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Dexamethasone—psoriasis	0.000824	0.0029	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Betamethasone—psoriasis	0.000824	0.0029	CcSEcCtD
Fidaxomicin—Skin disorder—Mycophenolic acid—psoriasis	0.000822	0.00289	CcSEcCtD
Fidaxomicin—Dysgeusia—Cyclosporine—psoriasis	0.000821	0.00289	CcSEcCtD
Fidaxomicin—Malnutrition—Mycophenolate mofetil—psoriasis	0.000818	0.00288	CcSEcCtD
Fidaxomicin—Vomiting—Acitretin—psoriasis	0.000818	0.00288	CcSEcCtD
Fidaxomicin—Vomiting—Fluocinolone Acetonide—psoriasis	0.000816	0.00287	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Prednisone—psoriasis	0.000812	0.00286	CcSEcCtD
Fidaxomicin—Rash—Acitretin—psoriasis	0.000811	0.00286	CcSEcCtD
Fidaxomicin—Dermatitis—Acitretin—psoriasis	0.00081	0.00285	CcSEcCtD
Fidaxomicin—Rash—Fluocinolone Acetonide—psoriasis	0.000809	0.00285	CcSEcCtD
Fidaxomicin—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000808	0.00285	CcSEcCtD
Fidaxomicin—Flatulence—Mycophenolate mofetil—psoriasis	0.000806	0.00284	CcSEcCtD
Fidaxomicin—Headache—Acitretin—psoriasis	0.000806	0.00284	CcSEcCtD
Fidaxomicin—Headache—Fluocinolone Acetonide—psoriasis	0.000804	0.00283	CcSEcCtD
Fidaxomicin—Abdominal distension—Prednisone—psoriasis	0.000801	0.00282	CcSEcCtD
Fidaxomicin—Dysgeusia—Mycophenolate mofetil—psoriasis	0.000801	0.00282	CcSEcCtD
Fidaxomicin—Anaemia—Cyclosporine—psoriasis	0.000775	0.00273	CcSEcCtD
Fidaxomicin—Immune system disorder—Hydrocortisone—psoriasis	0.000773	0.00272	CcSEcCtD
Fidaxomicin—Angioedema—Cyclosporine—psoriasis	0.000766	0.0027	CcSEcCtD
Fidaxomicin—Nausea—Acitretin—psoriasis	0.000764	0.00269	CcSEcCtD
Fidaxomicin—Nausea—Fluocinolone Acetonide—psoriasis	0.000762	0.00268	CcSEcCtD
Fidaxomicin—Anaemia—Mycophenolate mofetil—psoriasis	0.000756	0.00266	CcSEcCtD
Fidaxomicin—Dyspnoea—Mycophenolic acid—psoriasis	0.000754	0.00266	CcSEcCtD
Fidaxomicin—Angioedema—Mycophenolate mofetil—psoriasis	0.000747	0.00263	CcSEcCtD
Fidaxomicin—Malnutrition—Hydrocortisone—psoriasis	0.000745	0.00263	CcSEcCtD
Fidaxomicin—Dyspepsia—Mycophenolic acid—psoriasis	0.000745	0.00262	CcSEcCtD
Fidaxomicin—Hypersensitivity—Hydroxyurea—psoriasis	0.000744	0.00262	CcSEcCtD
Fidaxomicin—Neutropenia—Prednisone—psoriasis	0.000744	0.00262	CcSEcCtD
Fidaxomicin—Decreased appetite—Mycophenolic acid—psoriasis	0.000735	0.00259	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.00073	0.00257	CcSEcCtD
Fidaxomicin—Constipation—Mycophenolic acid—psoriasis	0.000723	0.00255	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Prednisone—psoriasis	0.000718	0.00253	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000709	0.0025	CcSEcCtD
Fidaxomicin—Dry mouth—Cyclosporine—psoriasis	0.000698	0.00246	CcSEcCtD
Fidaxomicin—Angioedema—Prednisolone—psoriasis	0.000697	0.00246	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000692	0.00244	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000692	0.00244	CcSEcCtD
Fidaxomicin—Dysgeusia—Triamcinolone—psoriasis	0.000687	0.00242	CcSEcCtD
Fidaxomicin—Dry mouth—Mycophenolate mofetil—psoriasis	0.000681	0.0024	CcSEcCtD
Fidaxomicin—Angioedema—Hydrocortisone—psoriasis	0.000681	0.0024	CcSEcCtD
Fidaxomicin—Nervous system disorder—Cyclosporine—psoriasis	0.000671	0.00236	CcSEcCtD
Fidaxomicin—Abdominal pain—Mycophenolic acid—psoriasis	0.000669	0.00236	CcSEcCtD
Fidaxomicin—Dizziness—Hydroxyurea—psoriasis	0.000668	0.00235	CcSEcCtD
Fidaxomicin—Skin disorder—Cyclosporine—psoriasis	0.000665	0.00234	CcSEcCtD
Fidaxomicin—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000655	0.00231	CcSEcCtD
Fidaxomicin—Skin disorder—Mycophenolate mofetil—psoriasis	0.000648	0.00228	CcSEcCtD
Fidaxomicin—Vomiting—Hydroxyurea—psoriasis	0.000642	0.00226	CcSEcCtD
Fidaxomicin—Angioedema—Triamcinolone—psoriasis	0.000641	0.00226	CcSEcCtD
Fidaxomicin—Rash—Hydroxyurea—psoriasis	0.000637	0.00224	CcSEcCtD
Fidaxomicin—Dermatitis—Hydroxyurea—psoriasis	0.000636	0.00224	CcSEcCtD
Fidaxomicin—Headache—Hydroxyurea—psoriasis	0.000633	0.00223	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.00063	0.00222	CcSEcCtD
Fidaxomicin—Neutropenia—Methotrexate—psoriasis	0.000622	0.00219	CcSEcCtD
Fidaxomicin—Dyspnoea—Cyclosporine—psoriasis	0.00061	0.00215	CcSEcCtD
Fidaxomicin—Dyspepsia—Cyclosporine—psoriasis	0.000602	0.00212	CcSEcCtD
Fidaxomicin—Nausea—Hydroxyurea—psoriasis	0.0006	0.00211	CcSEcCtD
Fidaxomicin—Pruritus—Mycophenolic acid—psoriasis	0.000598	0.00211	CcSEcCtD
Fidaxomicin—Nervous system disorder—Hydrocortisone—psoriasis	0.000596	0.0021	CcSEcCtD
Fidaxomicin—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000595	0.0021	CcSEcCtD
Fidaxomicin—Decreased appetite—Cyclosporine—psoriasis	0.000595	0.0021	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000591	0.00208	CcSEcCtD
Fidaxomicin—Skin disorder—Hydrocortisone—psoriasis	0.000591	0.00208	CcSEcCtD
Fidaxomicin—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000588	0.00207	CcSEcCtD
Fidaxomicin—Constipation—Cyclosporine—psoriasis	0.000585	0.00206	CcSEcCtD
Fidaxomicin—Dry mouth—Triamcinolone—psoriasis	0.000584	0.00206	CcSEcCtD
Fidaxomicin—Angioedema—Dexamethasone—psoriasis	0.000582	0.00205	CcSEcCtD
Fidaxomicin—Angioedema—Betamethasone—psoriasis	0.000582	0.00205	CcSEcCtD
Fidaxomicin—Decreased appetite—Mycophenolate mofetil—psoriasis	0.00058	0.00204	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000576	0.00203	CcSEcCtD
Fidaxomicin—Immune system disorder—Prednisone—psoriasis	0.000575	0.00203	CcSEcCtD
Fidaxomicin—Constipation—Mycophenolate mofetil—psoriasis	0.000571	0.00201	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Methotrexate—psoriasis	0.000561	0.00198	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Cyclosporine—psoriasis	0.00056	0.00197	CcSEcCtD
Fidaxomicin—Dizziness—Mycophenolic acid—psoriasis	0.000559	0.00197	CcSEcCtD
Fidaxomicin—Malnutrition—Prednisone—psoriasis	0.000554	0.00195	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000546	0.00192	CcSEcCtD
Fidaxomicin—Abdominal pain—Cyclosporine—psoriasis	0.000541	0.00191	CcSEcCtD
Fidaxomicin—Vomiting—Mycophenolic acid—psoriasis	0.000538	0.00189	CcSEcCtD
Fidaxomicin—Dyspepsia—Hydrocortisone—psoriasis	0.000535	0.00189	CcSEcCtD
Fidaxomicin—Rash—Mycophenolic acid—psoriasis	0.000533	0.00188	CcSEcCtD
Fidaxomicin—Dermatitis—Mycophenolic acid—psoriasis	0.000533	0.00188	CcSEcCtD
Fidaxomicin—Headache—Mycophenolic acid—psoriasis	0.00053	0.00187	CcSEcCtD
Fidaxomicin—Decreased appetite—Hydrocortisone—psoriasis	0.000529	0.00186	CcSEcCtD
Fidaxomicin—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000528	0.00186	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000525	0.00185	CcSEcCtD
Fidaxomicin—Anaemia—Prednisone—psoriasis	0.000512	0.00181	CcSEcCtD
Fidaxomicin—Dyspnoea—Triamcinolone—psoriasis	0.000511	0.0018	CcSEcCtD
Fidaxomicin—Nervous system disorder—Dexamethasone—psoriasis	0.00051	0.0018	CcSEcCtD
Fidaxomicin—Nervous system disorder—Betamethasone—psoriasis	0.00051	0.0018	CcSEcCtD
Fidaxomicin—Angioedema—Prednisone—psoriasis	0.000507	0.00178	CcSEcCtD
Fidaxomicin—Hypersensitivity—Cyclosporine—psoriasis	0.000504	0.00178	CcSEcCtD
Fidaxomicin—Dyspepsia—Triamcinolone—psoriasis	0.000504	0.00178	CcSEcCtD
Fidaxomicin—Nausea—Mycophenolic acid—psoriasis	0.000502	0.00177	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000497	0.00175	CcSEcCtD
Fidaxomicin—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000492	0.00173	CcSEcCtD
Fidaxomicin—Pruritus—Cyclosporine—psoriasis	0.000484	0.00171	CcSEcCtD
Fidaxomicin—Immune system disorder—Methotrexate—psoriasis	0.000481	0.00169	CcSEcCtD
Fidaxomicin—Abdominal pain—Hydrocortisone—psoriasis	0.000481	0.00169	CcSEcCtD
Fidaxomicin—Pruritus—Mycophenolate mofetil—psoriasis	0.000472	0.00166	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000469	0.00165	CcSEcCtD
Fidaxomicin—Malnutrition—Methotrexate—psoriasis	0.000463	0.00163	CcSEcCtD
Fidaxomicin—Hypersensitivity—Prednisolone—psoriasis	0.000459	0.00162	CcSEcCtD
Fidaxomicin—Dyspepsia—Betamethasone—psoriasis	0.000457	0.00161	CcSEcCtD
Fidaxomicin—Dyspepsia—Dexamethasone—psoriasis	0.000457	0.00161	CcSEcCtD
Fidaxomicin—Dysgeusia—Methotrexate—psoriasis	0.000454	0.0016	CcSEcCtD
Fidaxomicin—Dizziness—Cyclosporine—psoriasis	0.000453	0.00159	CcSEcCtD
Fidaxomicin—Decreased appetite—Dexamethasone—psoriasis	0.000452	0.00159	CcSEcCtD
Fidaxomicin—Decreased appetite—Betamethasone—psoriasis	0.000452	0.00159	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000449	0.00158	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Betamethasone—psoriasis	0.000449	0.00158	CcSEcCtD
Fidaxomicin—Hypersensitivity—Hydrocortisone—psoriasis	0.000448	0.00158	CcSEcCtD
Fidaxomicin—Nervous system disorder—Prednisone—psoriasis	0.000444	0.00156	CcSEcCtD
Fidaxomicin—Dizziness—Mycophenolate mofetil—psoriasis	0.000441	0.00156	CcSEcCtD
Fidaxomicin—Skin disorder—Prednisone—psoriasis	0.00044	0.00155	CcSEcCtD
Fidaxomicin—Vomiting—Cyclosporine—psoriasis	0.000435	0.00153	CcSEcCtD
Fidaxomicin—Rash—Cyclosporine—psoriasis	0.000431	0.00152	CcSEcCtD
Fidaxomicin—Dermatitis—Cyclosporine—psoriasis	0.000431	0.00152	CcSEcCtD
Fidaxomicin—Pruritus—Hydrocortisone—psoriasis	0.00043	0.00152	CcSEcCtD
Fidaxomicin—Headache—Cyclosporine—psoriasis	0.000429	0.00151	CcSEcCtD
Fidaxomicin—Anaemia—Methotrexate—psoriasis	0.000428	0.00151	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Betamethasone—psoriasis	0.000425	0.0015	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Dexamethasone—psoriasis	0.000425	0.0015	CcSEcCtD
Fidaxomicin—Vomiting—Mycophenolate mofetil—psoriasis	0.000424	0.0015	CcSEcCtD
Fidaxomicin—Hypersensitivity—Triamcinolone—psoriasis	0.000422	0.00149	CcSEcCtD
Fidaxomicin—Rash—Mycophenolate mofetil—psoriasis	0.000421	0.00148	CcSEcCtD
Fidaxomicin—Dermatitis—Mycophenolate mofetil—psoriasis	0.000421	0.00148	CcSEcCtD
Fidaxomicin—Headache—Mycophenolate mofetil—psoriasis	0.000418	0.00147	CcSEcCtD
Fidaxomicin—Dizziness—Prednisolone—psoriasis	0.000412	0.00145	CcSEcCtD
Fidaxomicin—Abdominal pain—Betamethasone—psoriasis	0.000411	0.00145	CcSEcCtD
Fidaxomicin—Abdominal pain—Dexamethasone—psoriasis	0.000411	0.00145	CcSEcCtD
Fidaxomicin—Nausea—Cyclosporine—psoriasis	0.000406	0.00143	CcSEcCtD
Fidaxomicin—Pruritus—Triamcinolone—psoriasis	0.000405	0.00143	CcSEcCtD
Fidaxomicin—Dizziness—Hydrocortisone—psoriasis	0.000402	0.00142	CcSEcCtD
Fidaxomicin—Dyspepsia—Prednisone—psoriasis	0.000398	0.0014	CcSEcCtD
Fidaxomicin—Nausea—Mycophenolate mofetil—psoriasis	0.000397	0.0014	CcSEcCtD
Fidaxomicin—Decreased appetite—Prednisone—psoriasis	0.000393	0.00139	CcSEcCtD
Fidaxomicin—Rash—Prednisolone—psoriasis	0.000393	0.00138	CcSEcCtD
Fidaxomicin—Dermatitis—Prednisolone—psoriasis	0.000392	0.00138	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000392	0.00138	CcSEcCtD
Fidaxomicin—Headache—Prednisolone—psoriasis	0.00039	0.00137	CcSEcCtD
Fidaxomicin—Constipation—Prednisone—psoriasis	0.000387	0.00136	CcSEcCtD
Fidaxomicin—Vomiting—Hydrocortisone—psoriasis	0.000387	0.00136	CcSEcCtD
Fidaxomicin—Rash—Hydrocortisone—psoriasis	0.000383	0.00135	CcSEcCtD
Fidaxomicin—Dermatitis—Hydrocortisone—psoriasis	0.000383	0.00135	CcSEcCtD
Fidaxomicin—Headache—Hydrocortisone—psoriasis	0.000381	0.00134	CcSEcCtD
Fidaxomicin—Dizziness—Triamcinolone—psoriasis	0.000379	0.00133	CcSEcCtD
Fidaxomicin—Nervous system disorder—Methotrexate—psoriasis	0.000371	0.00131	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Prednisone—psoriasis	0.00037	0.0013	CcSEcCtD
Fidaxomicin—Nausea—Prednisolone—psoriasis	0.00037	0.0013	CcSEcCtD
Fidaxomicin—Pruritus—Betamethasone—psoriasis	0.000368	0.00129	CcSEcCtD
Fidaxomicin—Pruritus—Dexamethasone—psoriasis	0.000368	0.00129	CcSEcCtD
Fidaxomicin—Skin disorder—Methotrexate—psoriasis	0.000367	0.00129	CcSEcCtD
Fidaxomicin—Vomiting—Triamcinolone—psoriasis	0.000364	0.00128	CcSEcCtD
Fidaxomicin—Nausea—Hydrocortisone—psoriasis	0.000361	0.00127	CcSEcCtD
Fidaxomicin—Rash—Triamcinolone—psoriasis	0.000361	0.00127	CcSEcCtD
Fidaxomicin—Dermatitis—Triamcinolone—psoriasis	0.000361	0.00127	CcSEcCtD
Fidaxomicin—Headache—Triamcinolone—psoriasis	0.000359	0.00126	CcSEcCtD
Fidaxomicin—Abdominal pain—Prednisone—psoriasis	0.000358	0.00126	CcSEcCtD
Fidaxomicin—Dizziness—Betamethasone—psoriasis	0.000344	0.00121	CcSEcCtD
Fidaxomicin—Dizziness—Dexamethasone—psoriasis	0.000344	0.00121	CcSEcCtD
Fidaxomicin—Nausea—Triamcinolone—psoriasis	0.00034	0.0012	CcSEcCtD
Fidaxomicin—Dyspnoea—Methotrexate—psoriasis	0.000337	0.00119	CcSEcCtD
Fidaxomicin—Hypersensitivity—Prednisone—psoriasis	0.000333	0.00117	CcSEcCtD
Fidaxomicin—Dyspepsia—Methotrexate—psoriasis	0.000333	0.00117	CcSEcCtD
Fidaxomicin—Vomiting—Dexamethasone—psoriasis	0.00033	0.00116	CcSEcCtD
Fidaxomicin—Vomiting—Betamethasone—psoriasis	0.00033	0.00116	CcSEcCtD
Fidaxomicin—Decreased appetite—Methotrexate—psoriasis	0.000329	0.00116	CcSEcCtD
Fidaxomicin—Rash—Betamethasone—psoriasis	0.000328	0.00115	CcSEcCtD
Fidaxomicin—Rash—Dexamethasone—psoriasis	0.000328	0.00115	CcSEcCtD
Fidaxomicin—Dermatitis—Betamethasone—psoriasis	0.000327	0.00115	CcSEcCtD
Fidaxomicin—Dermatitis—Dexamethasone—psoriasis	0.000327	0.00115	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Methotrexate—psoriasis	0.000326	0.00115	CcSEcCtD
Fidaxomicin—Headache—Dexamethasone—psoriasis	0.000326	0.00115	CcSEcCtD
Fidaxomicin—Headache—Betamethasone—psoriasis	0.000326	0.00115	CcSEcCtD
Fidaxomicin—Pruritus—Prednisone—psoriasis	0.00032	0.00113	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Methotrexate—psoriasis	0.000309	0.00109	CcSEcCtD
Fidaxomicin—Nausea—Betamethasone—psoriasis	0.000309	0.00109	CcSEcCtD
Fidaxomicin—Nausea—Dexamethasone—psoriasis	0.000309	0.00109	CcSEcCtD
Fidaxomicin—Dizziness—Prednisone—psoriasis	0.000299	0.00105	CcSEcCtD
Fidaxomicin—Abdominal pain—Methotrexate—psoriasis	0.000299	0.00105	CcSEcCtD
Fidaxomicin—Vomiting—Prednisone—psoriasis	0.000288	0.00101	CcSEcCtD
Fidaxomicin—Rash—Prednisone—psoriasis	0.000285	0.00101	CcSEcCtD
Fidaxomicin—Dermatitis—Prednisone—psoriasis	0.000285	0.001	CcSEcCtD
Fidaxomicin—Headache—Prednisone—psoriasis	0.000283	0.000999	CcSEcCtD
Fidaxomicin—Hypersensitivity—Methotrexate—psoriasis	0.000279	0.000981	CcSEcCtD
Fidaxomicin—Nausea—Prednisone—psoriasis	0.000269	0.000947	CcSEcCtD
Fidaxomicin—Pruritus—Methotrexate—psoriasis	0.000268	0.000943	CcSEcCtD
Fidaxomicin—Dizziness—Methotrexate—psoriasis	0.00025	0.000881	CcSEcCtD
Fidaxomicin—Vomiting—Methotrexate—psoriasis	0.00024	0.000847	CcSEcCtD
Fidaxomicin—Rash—Methotrexate—psoriasis	0.000238	0.00084	CcSEcCtD
Fidaxomicin—Dermatitis—Methotrexate—psoriasis	0.000238	0.000839	CcSEcCtD
Fidaxomicin—Headache—Methotrexate—psoriasis	0.000237	0.000835	CcSEcCtD
Fidaxomicin—Nausea—Methotrexate—psoriasis	0.000225	0.000791	CcSEcCtD
